UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo?

Rusakiewicz, S; Dodi, IA; Loconto, J; Travers, PJ; Madrigal, JA; (2004) Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells, Molecules, and Diseases , 33 (3) p. 191.

Full text not available from this repository.
Type: Article
Title: Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo?
Additional information: WoS ID: 000225114500028 JournalEnglishMeeting AbstractACADEMIC PRESS INC ELSEVIER SCIENCENOV-DEC871FFSAN DIEGORoyal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, EnglandBLOOD CELLS MOLECULES DIS525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
Keywords: BLOOD, blood-cell, CELL, CELLS, ENGLAND, FUSION, immunotherapy, IN-VIVO, LONDON, MOLECULE, MOLECULES, patient, Patients, peptide, T cell, T-CELLS, VIVO
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/181944
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item